🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Elite Pharmaceuticals, Inc. (ELTP)
OTCMKTS · Delayed Price · Currency is USD
0.32472
+0.00082 (0.25%)
At close: Nov 20, 2026

Elite Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
34.8629.811.327.117.838.54
Cash & Short-Term Investments
34.8629.811.327.117.838.54
Cash Growth
30.98%163.34%59.23%-9.27%-8.24%167.33%
Receivables
63.2259.7229.2119.453.093.06
Inventory
22.5221.2616.2412.939.556.74
Prepaid Expenses
0.141.330.980.521.030.53
Total Current Assets
120.74112.1157.7440.0121.5118.86
Property, Plant & Equipment
13.5413.0114.114.6110.446.98
Other Intangible Assets
4.79-0.290.290.290.47
Long-Term Deferred Tax Assets
4.647.8218.3722.162.172.17
Long-Term Deferred Charges
-4.795.356.056.056.17
Other Long-Term Assets
0.570.560.550.530.430.5
Total Assets
144.29138.2996.3983.6540.935.15

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
3.16.052.962.712.451.43
Accrued Expenses
6.279.63.454.824.634.28
Short-Term Debt
--44--
Current Portion of Long-Term Debt
0.240.230.250.30.310.35
Current Portion of Leases
0.970.920.840.720.010.2
Current Income Taxes Payable
-0.590.340.490.410.41
Current Unearned Revenue
--0.010.010.010.01
Other Current Liabilities
7.58-----
Total Current Liabilities
18.1517.3911.8413.057.836.69
Long-Term Debt
2.62.83.033.283.561.39
Long-Term Leases
1.371.872.83.44-0.84
Long-Term Unearned Revenue
---0.010.020.03
Other Long-Term Liabilities
-17.3425.26.30.520.98
Total Liabilities
22.1239.4142.8726.0711.949.93

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
1.081.081.071.071.011.01
Additional Paid-In Capital
174173.94173.46173.21164.75164.58
Retained Earnings
-52.6-75.83-120.7-116.39-136.5-140.06
Treasury Stock
-0.31-0.31-0.31-0.31-0.31-0.31
Total Common Equity
122.1798.8853.5257.5828.9625.22
Shareholders' Equity
122.1798.8853.5257.5828.9625.22
Total Liabilities & Equity
144.29138.2996.3983.6540.935.15

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
5.185.8210.9111.743.892.78
Net Cash (Debt)
29.6823.980.4-4.633.945.75
Net Cash Growth
46.08%5888.11%---31.44%606.63%
Net Cash Per Share
0.030.020.00-0.000.000.01
Filing Date Shares Outstanding
1,0781,0771,0681,0681,0141,011
Total Common Shares Outstanding
1,0771,0771,0681,0681,0141,011
Working Capital
102.5994.7245.926.9613.6812.17
Book Value Per Share
0.110.090.050.050.030.02
Tangible Book Value
117.3798.8853.2357.2928.6724.76
Tangible Book Value Per Share
0.110.090.050.050.030.02
Land
-11.6511.6511.0610.775.46
Machinery
-16.6315.7115.0214.2413.85